4/A

FORM 4/A SUBMISSION

Company: Akebia Therapeutics, Inc.
Filed: June 9, 2015
Period of Report: April 1, 2015
Accession Number: 0001209191-15-051426

View Document ↗ View on SEC.gov ↗